课题基金 / 基金详情

MODEL PARAMETERS FOR ANTHRACYCLINE DRUGS

MODEL PARAMETERS FOR ANTHRACYCLINE DRUGS
蒽环类药物的模型参数
批准号:
3166576
负责人:
HERBERT S SCHWARTZ
金额:
$8.58万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-01-01 至 1985-12-31

项目摘要

项目成果

HERBERT S SCHWARTZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Some of the drugs that interact with DNA are among our most useful drugs in the treatment of neoplastic diseases. The agents and many derivatives bind to DNA and produce strand scission. We developed a model to evaluate parameters of their actions and now use the model to study drug metabolism and activation in tumors and in tissues that are selectively intoxicated. Studies are carried out with tumor cells and membranes and animal mitochondria, microsomes, and enzymes to define the systems of activation and to evaluate the means for control of their toxicity. Studies with phospholipids and enzymes indicate biotransformation of the agents to forms that may be proximal to the final reactants which bind covalently to macromolecules. Pharmacokinetic studies in progress are aimed to relate in vitro drug metabolism and drug activation to biological activity of the agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CANCER MODELS FOR DNA-INTERACTING DRUGS
  • 批准号:
    3166575
  • 项目类别:
  • 资助金额:
    $13.3万
  • 财政年份:
    1979
  • 负责人:
    HERBERT S SCHWARTZ
  • 依托单位:
CANCER MODELS FOR DNA-INTERACTING DRUGS
  • 批准号:
    3166577
  • 项目类别:
  • 资助金额:
    $12.44万
  • 财政年份:
    1979
  • 负责人:
    HERBERT S SCHWARTZ
  • 依托单位:
HISTORADIOLOGY OF BONE BIOPSY AND ALTERATION IN MRI SIGNAL
  • 批准号:
    3909471
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    HERBERT S SCHWARTZ
  • 依托单位:
TRANSFORMING GROWTH FACTOR BETA (TGF BETA) BINDING TO HUMAN OSTEOBLASTS
  • 批准号:
    3868838
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    HERBERT S SCHWARTZ
  • 依托单位:
海外基金